![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Open Price
1.40Prev. Close
1.1300Volume
6934216.00Value
9014480.80Market Cap
51.80
Price to Earnings
60.60
Price to Book Value
0.80
Dividend Yield
0.00
PE to Growth
-0.90
Op Revenue TTM
20.28
Net Profit TTM
0.85
Cash From Operating Activity
10.16
Return on Equity %
0.98
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
05 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
1.43
Second Resistance
1.47
Third Resistance
1.55
First Support
1.31
Second Support
1.23
Third Support
1.19
Relative Strength Index
77.92
Money Flow Index
72.67
MACD
0.02
MACD Signal
0
Average True Range
0.04
Average Directional Index
23.39
Rate of Change (21)
27.52
Rate of Change (125)
-10.32
Commodity Channel Index
478.9
Williams %R
BETA
1 Month
-0.64
3 Month
0.27
1 Year
0.54
3 Year
0.42
PRICE CHANGE ANALYSIS
1 Week
Low
High
1.14
1.44
1 Month
Low
High
1.09
1.44
3 Months
Low
High
1.07
1.44
6 Months
Low
High
1.05
1.59
1 Year
Low
High
0.7
1.89
Shree Ganesh Biotech (India) Ltd - 539470 - Disclosure Under Regulation 32(1) Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 32(1) of SEBI (LODR) Regulations, 2015Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Outcome for Audited Financial Results For The Year Ended On March 31, 2024
Out come of Board Meeting held on 30th May, 2024Shree Ganesh Biotech (India) Ltd - 539470 - Submission Of Audited Financial Results March 31, 2024
Audited Financial Results for the year ended on 31st March, 2024Shree Ganesh Biotech (India) Ltd - 539470 - Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting.
Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 30th May 2024 at registered office of the company inter alia, to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You.The latest market price of Shree Ganesh Bio-Tech (India) Ltd. on NSE was Rs. 1.30 as of today.
The opening share price of Shree Ganesh Bio-Tech (India) Ltd. was Rs. 1.40 as of today.
The 52-week high share price of Shree Ganesh Bio-Tech (India) Ltd. was Rs. 1.90.
The 52 week low share price of Shree Ganesh Bio-Tech (India) Ltd. was Rs. 0.70.
The PE ratio of Shree Ganesh Bio-Tech (India) Ltd. is -0.90. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest bonus issue declared by Shree Ganesh Bio-Tech (India) Ltd. was as of 2022-04-27. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Shree Ganesh Bio-Tech (India) Ltd. was as of 2022-02-10. The split ratio declared in this issue was 10:1. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Shree Ganesh Bio-Tech (India) Ltd..